The European Medicines Agency will decide on a coronavirus vaccine produced by Moderna on January 6, 2021.
Moderna submitted the final set of documents required for the assessment ahead of schedule on December 17. It contains data related to the production of the drug for the European market.
Considering the achieved process, the meeting of the profile committee to complete the evaluation of the vaccine is scheduled for January 6, TASS quotes the statement of the European regulator.
The meeting is to take place on January 12, 2021.
American company Moderna has sufficient capacity to provide the European Union with more vaccine doses against coronavirus infection than the ordered 80 million, corporation chief Stéphane Bancel said. According to him, the company can supply the EU with 300 million doses of the drug. The top executive noted that the United States is not the primary market for Moderna and added that 'the vaccine created by Moderna will provide 94% of patients with 100% protection against COVID-19.'
NEWS.ru reported earlier that scientists in Russia were working on 26 variants of a vaccine against coronavirus, said Minister of Health Anna Popova. According to her, medicines are being developed by 17 scientific institutions.